We are Sorry, This Page doesn't Exist

Myovant and Pfizer are also.....»»

Filing thousands of pages of data electronically from remote locations as employees sheltered in place against Covid-19, Myovant Sciences asked regulators Tuesday to quickly approve its once-a-day pill against prostate cancer. The Brisbane company a.....»»

Prostock-studio / Shutterstock An estimated 15% of couples experience infertility at some point and sometimes, there is no explanation for infertility. Frequent bicycle riding, poor diet, testosterone and prostate cancer medications, as well as .....»»

Progenics Pharmaceuticals, Inc. said Monday a late-stage trial of a treatment for prostate cancer met.....»»

Pfizer Inc. .....»»

Johnson & Johnson"s Nod For Prostate Cancer Drug May Offer Hope To Specific Patients.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scali.....»»

Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts......»»

Moleculin Biotech Inc (NASDAQ: MBRX)'s stock was advancing Wednesday on heavy volume. read more.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Bayer (BAYRY) submits an MAA for darolutamide in EU for the treatment of patients with non-metastatic castration-resista.....»»

Sophiris Bio Inc. shares plummeted nearly 46% in prem.....»»

Lilly (LLY) gets a favorable ruling from a U.S. district court in a patent related dispute against Dr. Reddy's Laboratories, concerning its key cancer drug Alimta's vitamin regi.....»»

Here's what you need to know. Several drug companies have recalled medications containing valsartan, an off-patent ingredient used in generic.....»»

A dark comedy dominating the Chinese box office this summer has tapped into public discontent about pharmaceutical costs, and is being linked to a new government effort to tamp down prices of cancer drugs......»»

J&J (JNJ) and Novartis (NVS) kick off earnings for pharma sector on a strong note. FDA approves J&J's latest HIV medicine and line extension of Pfizer's prostate cancer drug. .....»»

Vancouver-based CytoDyn Inc. (OTC.QB:CYDY), which is developing an HIV therapy, has signed a letter of intent to acquire ProstaGene LLC, which is focused on prostate cancer diagnostics and therapeutics. Cytodyn CEO Nader Pourhassan said he expects.....»»

A Chinese cancer drug developer is pushing ahead with an initial public offering in Hong Kong, despite a global markets rout and the recent poor performance of other biotechnology startups that have listed in the city......»»

Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»

Johnson & Johnson fell the most since February after a U.S. appeals court refused to stop generic versions of its prostate-cancer drug Zytiga from entering the market......»»